Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Angiodynamics Inc (ANGO)

Angiodynamics Inc (ANGO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 352,560
  • Shares Outstanding, K 37,869
  • Annual Sales, $ 264,160 K
  • Annual Income, $ -165,790 K
  • 60-Month Beta 0.62
  • Price/Sales 1.31
  • Price/Cash Flow 12.56
  • Price/Book 0.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 08/31/20
See More
  • Average Estimate -0.06
  • Number of Estimates 2
  • High Estimate -0.05
  • Low Estimate -0.07
  • Prior Year 0.08
  • Growth Rate Est. (year over year) -175.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.05 +17.39%
on 07/31/20
10.75 -12.09%
on 07/15/20
-0.75 (-7.35%)
since 07/13/20
3-Month
8.05 +17.39%
on 07/31/20
12.36 -23.54%
on 06/08/20
-0.76 (-7.44%)
since 05/13/20
52-Week
7.48 +26.34%
on 03/18/20
19.59 -51.76%
on 09/23/19
-9.66 (-50.55%)
since 08/13/19

Most Recent Stories

More News
New Strong Sell Stocks for August 5th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

ANGO : 9.43 (+1.29%)
ULTA : 220.82 (+1.40%)
KEX : 49.64 (-1.04%)
WWD : 85.22 (-0.54%)
GOOS : 23.83 (+2.67%)
AngioDynamics to Participate in a Virtual Fireside Chat at the Canaccord Genuity Growth Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer,...

ANGO : 9.43 (+1.29%)
New Strong Sell Stocks for August 3rd

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

ANGO : 9.43 (+1.29%)
BIP : 44.92 (-1.12%)
JJSF : 131.76 (+0.28%)
ETM : 1.7300 (+12.34%)
HESM : 18.60 (+0.16%)
AngioDyanamics (ANGO) Reports Q4 Loss, Revenues Lag Estimates

AngioDyanamics (ANGO) witnessed revenue decline across all business segments in Q4.

ANGO : 9.43 (+1.29%)
RMD : 177.87 (+1.15%)
OPK : 4.90 (+3.81%)
VRAY : 3.29 (+0.92%)
AngioDynamics (ANGO) Reports Q4 Loss, Lags Revenue Estimates

AngioDynamics (ANGO) delivered earnings and revenue surprises of -20.00% and -6.28%, respectively, for the quarter ended May 2020. Do the numbers hold clues to what lies ahead for the stock?

ANGO : 9.43 (+1.29%)
AngioDynamics Reports Fiscal 2020 Fourth Quarter and Full-Year Financial Results

--Full-Year 2020 Highlights

ANGO : 9.43 (+1.29%)
AngioDynamics to Report Fiscal 2020 Fourth Quarter and Full-Year Financial Results on July 16, 2020

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report...

ANGO : 9.43 (+1.29%)
Buy These 5 Low Leverage Stocks to Avoid Debt-Related Risk

Exorbitant debt financing might even cause a corporation's bankruptcy in the worst-case scenario.

ANGO : 9.43 (+1.29%)
TSLA : 1,626.29 (+4.60%)
WST : 274.80 (+0.87%)
LAKE : 20.85 (+3.94%)
ECOM : 17.46 (+3.68%)
Here's Why You Should Add AngioDynamics to Your Portfolio

AngioDynamics (ANGO) continues to benefit from strategic buyouts and strong product portfolio.

ANGO : 9.43 (+1.29%)
LH : 189.30 (+0.64%)
WST : 274.80 (+0.87%)
APHA : 4.61 (+2.22%)
AngioDynamics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer,...

ANGO : 9.43 (+1.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade ANGO with:

Business Summary

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad...

See More

Key Turning Points

2nd Resistance Point 9.56
1st Resistance Point 9.44
Last Price 9.43
1st Support Level 9.11
2nd Support Level 8.90

See More

52-Week High 19.59
Fibonacci 61.8% 14.96
Fibonacci 50% 13.53
Fibonacci 38.2% 12.11
Last Price 9.43
52-Week Low 7.48

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar